➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Colorcon
Medtronic
Baxter
Boehringer Ingelheim

Last Updated: June 3, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SYMMETREL

» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Symmetrel

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00627250 Utility of Amantadine Hydrochloride in the Treatment of Post-traumatic Irritability Completed U.S. Department of Education N/A 2003-03-01 The purpose of this study is to determine if amantadine hydrochloride given 100 mg in the morning and at noon is safe and effective in the treatment of mood and behavior changes (i.e. irritability) after sustaining traumatic brain injury.
NCT00627250 Utility of Amantadine Hydrochloride in the Treatment of Post-traumatic Irritability Completed Carolinas Healthcare System N/A 2003-03-01 The purpose of this study is to determine if amantadine hydrochloride given 100 mg in the morning and at noon is safe and effective in the treatment of mood and behavior changes (i.e. irritability) after sustaining traumatic brain injury.
NCT00867139 TCAD vs. Monotherapy for Influenza A in Immunocompromised Patients Completed Fred Hutchinson Cancer Research Center Phase 1/Phase 2 2009-03-01 The purpose of this study is to assess the safety and tolerability of triple combination antiviral drug (TCAD) for use in immunocompromised patients with Influenza A infection, and to gain data on the effectiveness of TCAD
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Symmetrel

Condition Name

Condition Name for Symmetrel
Intervention Trials
Traumatic Brain Injury 2
Parkinson's Disease 2
Aggression 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Symmetrel
Intervention Trials
Parkinson Disease 2
Brain Injuries 2
Dyskinesias 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Symmetrel

Trials by Country

Trials by Country for Symmetrel
Location Trials
United States 11
Canada 1
France 1
Austria 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Symmetrel
Location Trials
Illinois 3
New York 1
Pennsylvania 1
Oregon 1
North Carolina 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Symmetrel

Clinical Trial Phase

Clinical Trial Phase for Symmetrel
Clinical Trial Phase Trials
Phase 4 3
Phase 3 1
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Symmetrel
Clinical Trial Phase Trials
Completed 3
Recruiting 2
Terminated 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Symmetrel

Sponsor Name

Sponsor Name for Symmetrel
Sponsor Trials
Rush University Medical Center 1
Michael J. Fox Foundation for Parkinson's Research 1
Columbia University 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Symmetrel
Sponsor Trials
Other 9
U.S. Fed 2
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
McKesson
Mallinckrodt
Moodys
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.